As filed with the Securities and Exchange Commission on May 9, 2024

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Treace Medical Concepts, Inc.

(Exact name of registrant as specified in its charter)

Delaware

47-1052611

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification Number)

100 Palmetto Park Place

Ponte Vedra, Florida 32081

(Address, including zip code, of Principal Executive Offices)

 

2021 Incentive Award Plan

2021 Employee Stock Purchase Plan

(Full Title of the Plan)

 

Scot M. Elder

Chief Legal & Compliance Officer and Corporate Secretary

Treace Medical Concepts, Inc.

100 Palmetto Park Place

Ponte Vedra, Florida, 32801 (904) 373-5940

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Cathy Birkeland

Scott Westhoff

Latham & Watkins LLP

330 North Wabash Ave, Suite 2800

Chicago, IL 60611

Telephone: (312) 876-7700

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


 

 

 

 

 

 

 

Large accelerated filer

 

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 


EXPLANATORY NOTE

This Registration Statement on Form S-8 (this “Registration Statement”) is being filed with the Securities and Exchange Commission for the purpose of registering an additional 3,704,979 shares of common stock, par value $0.001 per share, of Treace Medical Concepts, Inc. (the “Registrant”) pursuant to the following employee benefit plans for which the Registration Statements of the Registrant on Form S-8 (File Nos. 333-255541, 333-263327 and 222-270352) are effective: (i) the 2021 Incentive Award Plan, as a result of the operation of an automatic annual increase provision therein, which added 3,087,482 shares of common stock, and (ii) the 2021 Employee Stock Purchase Plan, as a result of the operation of an automatic annual increase provision therein, which added 617,497 shares of common stock.

INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENT ON FORM S-

Pursuant to General Instruction E of Form S-8, the contents of the above referenced Registration Statements on Form S-8 filed with the Securities and Exchange Commission on April 27, 2021 (File No. 333-255541), March 4, 2022 (File No. 333-263327) and March 8, 2023 (File No. 333-270352), are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

 

 


Item 8. Exhibits.

EXHIBIT INDEX

 

 

 

 

 

 

 

 

 

 

 

 

 

Incorporated by Reference

Exhibit
Number

Description

Form

Exhibit

Date Filed

Filed
Herewith

 

 

 

 

 

 

4.1

Amended and Restated Certificate of Incorporation of Treace Medical Concepts, Inc.

8-K

 

3.1

 

 

4/27/2021

 

 

 

 

 

 

 

4.2

Amended and Restated Bylaws of the Treace Medical Concepts, Inc.

8-K

3.2

4/27/2021

 

 

 

 

 

 

 

4.3

 

Form of Common Stock Certificate

S-1/A

4.2

4/19/2021

 

 

 

 

 

 

 

5.1

Opinion of Latham & Watkins LLP

 

 

 

 

 

X

 

 

 

 

 

 

23.1

Consent of Latham & Watkins LLP (included in Exhibit 5.1)

 

 

 

 

 

X

 

 

 

 

 

 

23.2

Consent of Independent Registered Public Accounting Firm

 

 

 

 

 

X

 

 

 

 

 

 

24.1

Power of Attorney (included on the signature page to this Registration Statement)

 

 

 

 

 

X

 

 

 

 

 

 

99.1

2021 Incentive Award Plan and related form agreements

S-8

99.2

4/27/2021

 

 

 

 

 

 

 

99.2

2021 Employee Stock Purchase Plan

S-8

99.3

4/27/2021

 

 

 

 

 

 

 

107.1

Filing Fee Table.

 

 

 

 

 

X

 

 

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ponte Vedra, State of Florida, on this 9th day of May, 2024.

Treace Medical Concepts, Inc.

 

By: /s/ John T. Treace

John T. Treace

Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints John T. Treace, Mark L. Hair and Scot M. Elder, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution, for him or her in their name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement, including post-effective amendments or any abbreviated registration statement and any amendments thereto filed, with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

 

 

 

 

SIGNATURE

 

TITLE

 

DATE

 

 

 

/s/ John T. Treace

John T. Treace

 

Chief Executive Officer, Founder and Director (Principal Executive Officer)

 

May 9, 2024

 

 

 

/s/ Mark L. Hair

Mark L. Hair

 

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

May 9, 2024

 

 

 

/s/ James T. Treace

James T. Treace

 

Chairman of the Board

 

May 9, 2024

 

 

 

/s/ John K. Bakewell

John K. Bakewell

 

Director

 

May 9, 2024

 

 

 

/s/ Lance A. Berry

Lance A. Berry

 

 

Director

 

May 9, 2024

 

 

 

/s/ Lawrence W. Hamilton

Lawrence W. Hamilton

 

Director

 

May 9, 2024

 

 

 


/s/ Elizabeth S. Hanna

Elizabeth S. Hanna

 

 

Director

 

May 9, 2024

 

 

 

/s/ Deepti Jain

Deepti Jain

 

 

Director

 

May 9, 2024

 

 

 

/s/ Jane E. Kiernan

Jane E. Kiernan

 

 

Director

 

May 9, 2024

 

 

 

/s/ Richard W. Mott

Richard W. Mott

 

Director

 

May 9, 2024



ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-5.1

EX-23.2

EX-FILING FEES